A Johnson & Johnson unit working to resolve massive cancer litigation in bankruptcy court was accused by a former head of the ...
FDA reform needs to be underpinned by strategy, not ‘indiscriminate’ cuts The Trump administration could save the lives of ...
As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in ...
15h
GlobalData on MSNZevra sells priority review voucher for $150m to support drug launchesZevra has sold its US Food and Drug Administration (FDA) priority review voucher (PRV) for $150m to an undisclosed party.
Mr Johnson is an American entrepreneur and venture capitalist, best known for his anti-aging attempt that he refers to as ...
The company is leaning on its subcutaneous technology to deliver long-acting options that could prevent patients from cycling through drugs.
The "Seizures Pipeline Insight Analysis Report" drug pipelines has been added to ResearchAndMarkets.com's offering.The Seizures treatment pipeline analysis provides an overview of recent advancements ...
As Robert F. Kennedy Jr. takes the helm of the Department of Health and Human Services, his policies on chronic disease, ...
Stifel has initiated Compass Pathways (NASDAQ:CMPS) with a buy rating saying that stakeholders are starting to agree there is ...
UCB emerged as a major biopharmaceutical player in the 1990s with the development of blockbuster drugs Zyrtec and Keppra. Throughout the 1990s and early 2000s, UCB transformed from a hybrid ...
Rates of measles in the US have climbed significantly over the past 20 years, as vaccine skepticism has grown.
As we have discussed previously, there is an outbreak of measles affecting unvaccinated children in the US. In an attempt to reassure the US public, Robert F. Kennedy Jr., said that the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results